Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1

Author(s):  Riepl Mike

Issue:  May/Jun 2020 - Volume 24, Number 3
View All Articles in Issue

Abstract:  The often-debilitating ulcers that develop on the feet of patients with diabetes (i.e., “diabetic foot ulcers”) are among the most common types of chronic wounds. Their persistent failure to heal despite treatment is a significant cause of morbidity in a patient population often challenged by concomitant health conditions and quality-of-life issues. When a commercially manufactured therapy does not adequately heal such lesions, a compounded formulation may offer an effective alternative. In those customized medications, several drugs with different mechanisms of action can be combined in strengths or titrations compatible with each patient’s pharmacogenomics profile, and the formulation of a compound can be easily altered as healing progresses and/or the patient’s medical needs change. In this first in a series of 2 articles on compounding for the treatment of diabetic foot ulcers, the types, pathophysiologic causes, risk factors, and treatment of those lesions are discussed and formulations that promote their healing are provided. In part 2 of the series, differences in the healing of acute and chronic wounds are examined, the results of pharmacotherapy in treating diabetic foot ulcers are reviewed, the effectiveness of several drugs that promote chronic-wound healing is assessed, and additional formulations effective in treating nonhealing wounds are presented.

Related Keywords: Mike Riepl, RPh, diabetic foot ulcers, diabetes, chronic wound healing, drug combinations, nonhealing lesions, neuropathic ulcers, ischemic ulcers, neuroischemic ulcers, diabetic neuropathy, peripheral artery disease, arterial neuropathy, peripheral neuropathy, formulations, phenytoin, misoprostol, insulin, naltrexone hydrochloride, lidocaine hydrochloride, nifedipine, topical preparations, risk factors

Related Categories: DERMATOLOGY, DIABETES, FORMULATIONS, WOUND CARE, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Riepl Mike May/Jun 2020 182-186 Buy
Case Report: Wound Care of a Diabetic Foot Ulcer Wynn Tom Jul/Aug 2004 265-267 Buy
Five Compounds for Treating Diabetes-Related Conditions Meece Jerry May/Jun 2003 170-174 Buy
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Riepl Mike Jul/Aug 2020 278-281 Buy
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vail Jane Jan/Feb 2003 21-23 Buy
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane Jan/Feb 2017 22-27 Buy
Complications of Diabetes Key David M Mar/Apr 2000 88-90 Buy
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D Jul/Aug 2004 269-274 Buy
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers Gorman Shellie Mar/Apr 2000 94-96 Buy
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient Harshbarger Robert, Harshbarger Diana Mar/Apr 2000 84-87 Buy